Price Target

Wall Street's Most Accurate Analysts Give Their Take On 3 Defensive Stocks With Over 6% Dividend Yields

Franklin Covey Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Top Wall Street Forecasters Revamp UniFirst Price Expectations Ahead Of Q2 Earnings

As Wellness Spending Hits New Highs, Analyst Backs These Stocks

Wellness stocks are thriving as Gen Z and millennials prioritize fitness and recovery. Bank of America card data shows fitness spending at record highs, with pickleball participation up 46% year-over-year.

BWX Technologies Poised For Growth In Nuclear Power, Medical Radioisotopes Says Analyst

Seaport Global initiates coverage on BWX Technologies with a Buy rating. Analyst highlights strong growth potential and monopoly in US Navy nuclear reactors.

W.R. Berkley Nears Historical Price-To-Book High, Analyst Downgrades Stock On Overvaluation Concerns

BofA Securities analyst downgraded W.R. Berkley to Neutral, citing limited upside despite strong fundamentals and a high price-to-book ratio.

Alphabet Is A Massive Cash Flow Machine With An Under-Leveraged Balance Sheet: Analyst

WestPark Capital initiated coverage on Alphabet with a Buy rating and $210 price target. Despite missing Q4 estimates, Alphabet dominates the search market and has potential for growth in AI. Concerns about slowing growth in Google Cloud Platform and upcoming remedy trial.

Knight-Swift Faces Pressure With Lack Of Freight Flows Amid Tariffs, Analyst Downgrades Stock

BofA Securities downgraded Knight-Swift Transportation to Neutral, slashing its price target from $66 to $46. The revision reflects valuation concerns and declining earnings forecasts due to freight slowdowns and tariff impacts.

Valaris Needs More Cost-Cutting To Hit 2025 EBITDA Target: Analyst

JP Morgan lowers price target to $38, and warns of the need for further cost-cutting to meet 2025 EBITDA guidance amid ongoing market challenges.

Spotify Audiobooks, Ad Growth Drive Analyst Confidence

Analyst maintains Buy rating on Spotify with $700 PT. Expects profitability & FCF growth, confident in 2025 results.

TechTarget Faces Macro Challenges And Valuation Compression, Analyst Cuts Price Forecast

TechTarget's FY25 revenue guidance is expected to be in line with estimates at $512 million, but macroeconomic concerns could impact early 2025 performance. Needham analyst Joshua Reilly lowered the company's price target to $25 while maintaining a Buy rating.

Goldman Sachs Shakes Up Auto Parts Stocks: Downgrades Genuine Parts, Upgrades AutoZone Amid Economic Volatility

Goldman Sachs downgrades Genuine Parts to "Sell" due to market challenges, while upgrading AutoZone to "Neutral" amid improved performance and strong market positioning.

Ulta Beauty's Q1 Comp Momentum Turns This Analyst Bullish, Plus 'Tariff Risk Is Low'

Goldman Sachs analyst Kate McShane upgrades Ulta Beauty citing rebound in market share and potential for conservative 2025 guidance.

Apple Stock A Buy On 'Revenue Durability & Visibility': Analyst Highlights China Smartphone Sales Up In February

Apple could have good news with foreign-branded phone shipments up year-over-year in China for the month of February.

First Watch Sees Brighter 2025 With Improved Marketing, Lower Egg Costs, Says Analyst

The First Watch Restaurant Group's same store sales are expected to improve in 2025 due to marketing strategy changes and positive market trends.

BlackBerry Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Wall Street's Most Accurate Analysts Give Their Take On 3 Consumer Stocks Delivering High-Dividend Yields

Ulta Beauty To Rally Over 15%? Here Are 10 Top Analyst Forecasts For Tuesday

5 Stock Picks Last Month From Wall Street's Most Accurate Analysts

Top Wall Street Forecasters Revamp Sportsman's Warehouse Price Expectations Ahead Of Q4 Earnings

nCino Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Corcept Therapeutics Stock Jumps On Upbeat Ovarian Cancer Trial Data, Analysts Boost Price Forecast

Corcept's ROSELLA trial met its primary endpoint, showing relacorilant improved progression-free and overall survival in platinum-resistant ovarian cancer.

Virax Biolabs' Investigational Diagnostic Tests Has An Attractive Market Opportunity', Analyst Initiates With Buy Rating

Virax Biolabs' T-cell testing platform targets post-viral syndromes like Long COVID. HC Wainwright sees a major market opportunity, setting a $3 price target.

CAVA Can Outgrow Expectations With Strong Unit Economics And Market Headroom, Analyst Says

BofA Securities analyst Sara Senatore has initiated coverage on CAVA Group with a Buy rating and a price target of $112.00. The analyst highlights CAVA's strong financial model, growth potential, and ability to expand beyond its 1,000-store target, citing opportunities for increased customer spending and operational efficiency.

Top Wall Street Forecasters Revamp Progress Software Price Expectations Ahead Of Q1 Earnings

Noble Q1 Earnings Preview: Analyst Cuts Forecast On Idle Capacity, 2025 Guidance 'Remains Within Striking Distance'

Noble Corp (NE) is focused on securing contracts for idle rigs and reducing expenses, but analyst Arun Jayaram reaffirms Neutral rating with lower price target.

Lions Gate Entertainment: Starz, Lionsgate Studios Split Should Unlock Value

LGF.A separation of Starz and Lionsgate Studios expected after shareholder vote on 4/23. Analyst upgraded rating and sees potential for growth.

Tesla To $455? Here Are 10 Top Analyst Forecasts For Monday

5 Stocks In The Spotlight From Wall Street's Most Accurate Analysts Last Week

Wall Street's Most Accurate Analysts Weigh In On 3 Tech And Telecom Stocks With Over 3% Dividend Yields